Displaying 101 - 163 of 163

Entry IdEntry TitleAgencyJudge UsernameJudge EmailJudge DateVisual quality: Do the photography and/or the illustrations add intrigue or stopping power to the message?Art direction: Does the art element make me want to look at the piece?Message quality: Does the copy clearly communicate the intended message?Overall effectiveness: How well did the piece accomplish the desired results based on the objectives and results described in the applicant’s submission?Total Score
166Peritoneal dialysis ‘I could have stayed home’ campaignLemieux Bédardanthony.turowaturow@klick.comMay 11, 2022224513
166Peritoneal dialysis ‘I could have stayed home’ campaignLemieux Bédardjennifer.dilworthjdilworthfreelance@gmail.comMay 9, 2022433717
166Peritoneal dialysis ‘I could have stayed home’ campaignLemieux Bédardkris.riegerkris@mavenmm.comMay 18, 2022334717
166Peritoneal dialysis ‘I could have stayed home’ campaignLemieux Bédardmazen.baradhymazen.baradhy@gmail.comMay 9, 2022334313
166Peritoneal dialysis ‘I could have stayed home’ campaignLemieux Bédardpatrick.massadpatrickm@paab.caMay 7, 2022445922
15PersonalizeHemA AppRenegade Healthcare/Takeda Canada Inc.July 30, 20225551025
16PersonalizeHemA Digital Marketing CampaignRenegade Healthcare/Takeda Canada Inc.July 30, 20225551025
16PersonalizeHemA Digital Marketing CampaignRenegade Healthcare/Takeda Canada Inc.July 30, 20225551025
14PersonalizeHemA WebsiteRenegade Healthcare/Takeda Canada Inc.July 30, 20225551025
143PLACEHOLDER CampaignLampyon PLACEHOLDERJuly 30, 20225551025
143PLACEHOLDER CampaignLampyon PLACEHOLDERJuly 30, 20225551025
143PLACEHOLDER CampaignLampyon PLACEHOLDERjennifer.dilworthjdilworthfreelance@gmail.comMay 9, 202211114
143PLACEHOLDER CampaignLampyon PLACEHOLDERmazen.baradhymazen.baradhy@gmail.comMay 9, 202211114
144PLACEHOLDER2Lampyon PLACEHOLDER2July 30, 20225551025
144PLACEHOLDER2Lampyon PLACEHOLDER2July 30, 20225551025
144PLACEHOLDER2Lampyon PLACEHOLDER2jennifer.dilworthjdilworthfreelance@gmail.comMay 9, 202211114
144PLACEHOLDER2Lampyon PLACEHOLDER2mazen.baradhymazen.baradhy@gmail.comMay 9, 202211114
151POO TABOO CampaignToc Toc CommunicationsJuly 30, 20225551025
151POO TABOO CampaignToc Toc Communicationsanthony.turowaturow@klick.comMay 11, 2022234615
151POO TABOO CampaignToc Toc Communicationsjennifer.dilworthjdilworthfreelance@gmail.comMay 9, 2022444820
151POO TABOO CampaignToc Toc Communicationskris.riegerkris@mavenmm.comMay 18, 2022333615
151POO TABOO CampaignToc Toc Communicationsmazen.baradhymazen.baradhy@gmail.comMay 9, 2022444416
151POO TABOO CampaignToc Toc Communicationspatrick.massadpatrickm@paab.caMay 7, 2022554721
149PROPECIA HCP MaillerToc Toc CommunicationsMay 8, 2022445922
149PROPECIA HCP MaillerToc Toc Communicationsanthony.turowaturow@klick.comMay 11, 2022444820
149PROPECIA HCP MaillerToc Toc Communicationsmazen.baradhymazen.baradhy@gmail.comMay 9, 2022223512
148PROPECIA Starter KitToc Toc CommunicationsMay 8, 2022445922
148PROPECIA Starter KitToc Toc Communicationsanthony.turowaturow@klick.comMay 11, 2022222410
148PROPECIA Starter KitToc Toc Communicationsjennifer.dilworthjdilworthfreelance@gmail.comMay 9, 2022333615
148PROPECIA Starter KitToc Toc Communicationskris.riegerkris@mavenmm.comMay 18, 2022323715
148PROPECIA Starter KitToc Toc Communicationsmazen.baradhymazen.baradhy@gmail.comMay 9, 2022222410
13See the Possibilities DigitalCPC HealthcareJuly 30, 20225551025
12See the Possibilities PrintCPC HealthcareJuly 30, 20225551025
25Senior Brand ManagerTrois Prime / Bausch HealthJuly 30, 20225551025
18Showing on the insideLemieux Bédard Communications/Roche DiagnosticsJuly 30, 20225551025
10The Biktarvy Pill CampaignCPC HealthcareJuly 30, 20225551025
10The Biktarvy Pill CampaignCPC HealthcareJuly 30, 20225551025
17The New PapLemieux Bédard Communications/Roche DiagnosticsJuly 30, 20225551025
17The New PapLemieux Bédard Communications/Roche DiagnosticsJuly 30, 20225551025
155Understanding Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC) with Dr. Ricardo RendonBayer Canada, Canadian HealthJuly 30, 20225551025
155Understanding Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC) with Dr. Ricardo RendonBayer Canada, Canadian HealthJuly 30, 20225551025
155Understanding Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC) with Dr. Ricardo RendonBayer Canada, Canadian Healthanthony.turowaturow@klick.comMay 11, 202211114
155Understanding Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC) with Dr. Ricardo RendonBayer Canada, Canadian Healthjennifer.dilworthjdilworthfreelance@gmail.comMay 9, 2022224513
155Understanding Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC) with Dr. Ricardo RendonBayer Canada, Canadian Healthkris.riegerkris@mavenmm.comMay 18, 2022334818
155Understanding Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC) with Dr. Ricardo RendonBayer Canada, Canadian Healthmazen.baradhymazen.baradhy@gmail.comMay 9, 202211114
155Understanding Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC) with Dr. Ricardo RendonBayer Canada, Canadian Healthpatrick.massadpatrickm@paab.caMay 7, 2022334717
157Unexplained Shortness of BreathThe Adpharm Inc.July 30, 20225551025
157Unexplained Shortness of BreathThe Adpharm Inc.anthony.turowaturow@klick.comMay 11, 2022444820
157Unexplained Shortness of BreathThe Adpharm Inc.jennifer.dilworthjdilworthfreelance@gmail.comMay 9, 2022445922
157Unexplained Shortness of BreathThe Adpharm Inc.mazen.baradhymazen.baradhy@gmail.comMay 9, 2022555924
157Unexplained Shortness of BreathThe Adpharm Inc.patrick.massadpatrickm@paab.caMay 7, 2022444820
11XTANDI Baseball CampaignCPC HealthcareJuly 30, 20225551025
160You are not you COPDMcCann HealthJuly 30, 20225551025
160You are not you COPDMcCann Healthanthony.turowaturow@klick.comMay 11, 2022232613
160You are not you COPDMcCann Healthjennifer.dilworthjdilworthfreelance@gmail.comMay 9, 2022555924
160You are not you COPDMcCann Healthkris.riegerkris@mavenmm.comMay 18, 2022333615
160You are not you COPDMcCann Healthmazen.baradhymazen.baradhy@gmail.comMay 9, 2022334313
160You are not you COPDMcCann Healthpatrick.massadpatrickm@paab.caMay 7, 2022444921
147ZAXINE Print AdToc Toc CommunicationsMay 8, 2022545923
147ZAXINE Print AdToc Toc Communicationsanthony.turowaturow@klick.comMay 11, 2022444820
147ZAXINE Print AdToc Toc Communicationsjennifer.dilworthjdilworthfreelance@gmail.comMay 9, 2022543820
147ZAXINE Print AdToc Toc Communicationskris.riegerkris@mavenmm.comMay 18, 2022224715
147ZAXINE Print AdToc Toc Communicationsmazen.baradhymazen.baradhy@gmail.comMay 9, 2022454821
Entry IdEntry TitleAgencyJudge UsernameJudge EmailJudge DateVisual quality: Do the photography and/or the illustrations add intrigue or stopping power to the message?Art direction: Does the art element make me want to look at the piece?Message quality: Does the copy clearly communicate the intended message?Overall effectiveness: How well did the piece accomplish the desired results based on the objectives and results described in the applicant’s submission?Total Score